Background: Epidurals provide excellent analgesia for cardiac surgery and may reduce complications. However, their use has been tempered because of concern of the rare, but serious complication of epidural haematoma. The aim of this meta-analysis was to assess the effect of epidural on survival and the risk estimate of epidural haematoma. Methods: A systematic review of the literature (Pubmed, Embase, Scopus and the Cochrane Register) and a meta-analysis of the available randomized and case-matched studies were performed to estimate the effect on survival. An international, directed and viral anonymous survey was performed to identify the incidence of haematomas with a corresponding estimate of the number of epidurals performed. Results: Of 66 randomized and case-matched studies, 57 trials including 6383 patients reported the incidence of all-cause mortality at the longest follow up available, with a significant reduction with epidurals (59/3123 [1.9%] vs 108/3260 [3.3%] in the control arm, RR 0.65 [95% CI 0.48-0.86], P=0.003, NNT=70). No epidural haematoma was reported in these 66 trials (3320 epidurals). All other literature revealed nine haematomas in 13 100 patients. Through the anonymous, web-based, viral, international survey, we identified 16 further, non-published, epidural haematomas from 72 400 positioned epidurals. Therefore, a total of 25 haematomas have been identified from an estimate of 88 820 positioned epidurals, producing an estimated risk of 1:3552 (95% CI 1:2552-1:5841). Conclusions: The use of epidural analgesia in cardiac surgery is associated with a reduction in mortality (NNT=70), and with an estimated risk of epidural haematoma of 1:3552.
was 1:5000 and not different from those not receiving epidurals. Taken together, for every patient harmed by an epidural, nine lives could be potentially saved, indicating that benefit exceeded risk in this cohort. 3 Conversely, in cardiac surgery, the use of epidurals have been tempered worldwide as a result of the fear that the risk of epidural haematoma might be higher than in other surgical settings, because of the full-dose anticoagulation required for cardiopulmonary bypass (CPB). However, reports of epidural haematomas after placement or removal of the epidural catheter in cardiac surgery have been confined to case reports, with no haematomas described in large audits or randomized controlled trials (RCTs). Estimates of haematoma risk have been attempted over the yrs: using the mathematical model of Hanley and Lippman-Hand for an event that had not yet occurred, Ho AM and colleagues suggested a 95% confidence interval (CI) of 1:1500-1:150 000; 5 Bracco and colleagues more recently estimated it to be 1:12 000 (95% CI 1:2100-1:68 000), similar to the incidence of epidural haematoma in the non-obstetric, non-cardiac population (1:10 000, 95% CI 1:6700-1:14 900). 6 Further, it should not be forgotten that epidural haematomas can also occur spontaneously, as reported first in 1869 by Jackson. 7 Benefits of epidural analgesia have been investigated in cardiac surgery in more than 50 RCTs, most of them reporting positive effects on pain and secondary endpoints such as postoperative complications. However, even if postoperative pain is improved with epidurals, 8 benefits other than pain relief have been sought in order to balance the potential risk of haematoma. 9 Although most of those RCTs have involved low-risk patients undergoing coronary artery bypass surgery, prior meta-analyses have shown significant benefit with epidurals for a combined outcome of mortality and myocardial infarction, 10 for ventilation time, 10 for pulmonary complications, and supraventricular trachyarrhythmias. 11 However, neither meta-analysis was sufficiently large to show significant differences in mortality, despite a clinically important trend (odd ratio 0.71 10 and relative risk 0.81 11 ).
Therefore, an equipoise still exists for epidural use in cardiac surgery with the potential for a significant reduction in mortality and major complications vs the possibility of a greater haematoma risk than non-cardiac surgery (which does not require full anticoagulation for CPB). The deficiency in the current literature is that the sample size for mortality estimates has been too small to prove the relative risk reduction identified, and similarly continued fear that the epidural haematoma risk may be increased in cardiac surgery, despite repeated risk estimates suggesting that this is not increased. Published reports of epidural use and haematoma occurrence are skewed in both directions: to a lower incidence if only RCTs are analysed, as the incidence of haematoma (the numerator) is zero; to a higher incidence in case reports, since the denominator (the number of epidurals performed to produce the haematoma) is not reported.
Our research question was to perform an updated systematic review and meta-analysis, with a sample size that was large enough to show a real benefit or harm in terms of mortality, if present, and to conduct a worldwide survey to identify the risk of epidural haematoma, with identification of both numerator and denominator. The hypotheses based on the previous literature and risk estimates, were that the incidence of catheter-related haematoma was similar to that reported for thoracic epidural use in non-cardiac surgical settings, and that a mortality advantage would exist for epidural use in cardiac surgery.
Methods

Eligibility criteria
We searched all the reports regarding both cardiac surgery setting and an anaesthetic plan involving the use of epidural analgesia, and all reports of symptomatic epidural haematoma, with no language restriction.
For the meta-analysis of case-matched and RCTs, we selected all the manuscripts comparing one group of patients receiving epidural analgesia combined with general anaesthesia with one group of patients receiving general anaesthesia only for cardiac surgery. Non-human experimental protocols, studies not reporting data on mortality or myocardial infarction, and duplicate publications were excluded from the meta-analysis.
Information sources
An extensive search across different databases (Medline/PubMed, Pubmed Central, Embase, Scopus and the Cochrane Central Register of clinical trials) was performed on December 2013. Corresponding authors of published manuscripts were contacted directly.
Search strategies
The Pubmed search included '(epidural OR peridural OR neuraxial OR spinal) AND (cardiac OR cardiothoracic OR cardiovascular OR "heart surgery" OR "cardiovascular surgical procedures") AND (surgery OR surgical)'. The systematic review of the literature aimed to identify: (a) every case report or case series (including, but not limited to, RCTs and case-matched studies) where epidural was used in cardiac surgery; (b) every patient with catheter-related epidural haematoma occurring in cardiac surgery. To increase the sensitivity in identifying epidural haematomas we also used other sensitive search strings, which are listed in Supplementary material S1.
Worldwide survey
To determine both the incidence of haematoma (numerator) and the number of epidurals performed (denominator), we conducted a world-wide survey according to the following methods: 1. all survey responses were anonymous to encourage reporting; 2. all authors of any publications revealed in the prior literature search and all known experts in the field were sent survey forms; 3. all people contacted were encouraged to forward on the survey to anyone they knew who had performed epidurals for cardiac surgery; 4. all surveys were crosschecked within each country and against the literature to avoid duplication of the incidence of haematomas or number of epidurals performed. The detailed survey form is available in Supplementary material S2.
Study selection and data extraction
Results from database searches were screened at a title/abstract level by trained investigators. A difference in opinion as to the suitability of a reference was resolved by consensus after reviewing the full paper. Corresponding authors were contacted in order to obtain missing data where appropriate. For RCTs and casematched studies, data were extracted for mortality and myocardial infarction. The complete data extraction sheet is shown in Supplementary Table S1. When continuous outcome data were available as median and interquartile range (IQR) only, they were included in pooled analysis after approximation to normal distribution, using a standard transformation formula (IQR=SD 1.35 −1 , mean=median).
Outcomes
For the meta-analysis, the primary outcome was mortality, which was determined at the longest follow up available, whereas the secondary outcomes were myocardial infarction occurrence and length of mechanical ventilation. The incidence of epidural haematomas and the estimated total number of epidurals positioned in cardiac surgery worldwide were used to provide an estimate of risk.
Statistical analysis
All the randomized and case-matched trials meeting the eligibility criteria were included in the meta-analysis. A sub-analysis was performed including randomized studies only. Calculations were performed with Stata 11 (Stata Statistical Software: release 11, College Station, TX) and RevMan version 5.2 (a freeware available from The Cochrane Collaboration). The detailed meta-analysis methodology is presented in Supplementary material S3. We performed a quality assessment according to the Cochrane Collaboration methods, reported in Supplementary Table S2 . Sensitivity pooled analysis were performed including only randomized trials with low risk of bias, and then repeated with studies with low and moderate risk of bias.
The risk of epidural haematoma was calculated, dividing the number of haematomas by the total number of epidurals performed, with the Wilson Score Interval used to estimate the 95 and 99% confidence intervals.
The incidence of events and risk ratio with 95% CI are presented throughout. The absolute risk reduction is expressed as the number of patients needed to treat (NNT) to prevent an event, calculated as 100 (difference in % event rate between groups) −1 .
Results
Number of epidurals performed in cardiac surgical procedures worldwide
According to the eligibility criteria, we identified 66 published randomized (n=59) or case-matched trials (n=7) including 3320 patients who received epidural analgesia in cardiac surgery (see Fig. 1 , Table 1 , and, for references, Supplementary material S4 which also shows overlapping publications). In addition we retrieved 130 published case reports, case series and randomized trials not fulfilling the inclusion criteria for a total of further 13 100 patients (references available from authors at request). The anonymous web survey estimated an additional 72 400 epidurals positioned worldwide in the last 20 yrs, resulting in a total of 88 820 epidurals performed.
Meta-analysis
The primary outcome of mortality was reported in 57 publications including a total of 6383 patients (3123 who received epidurals and 3260 who received general anaesthesia only 2 =0%, NNT=70). The forest plot is shown as Fig. 2 . The funnel plot (Supplementary Fig. S1 ) investigated the possibility that small studies with negative effects were unpublished or less accessible than larger studies and clearly showed the absence of small study bias. A sub-analysis was performed on patients included in randomized studies only, which confirmed the direction and magnitude of mortality reduction with epidurals, though the sample size was insufficient to reach significance (27/ 2 =0%, NNT=78). The forest plot is shown as Supplementary Fig. S4 , and the funnel plot, confirming the absence of small study bias, is shown in Supplementary Fig. S5 . Length of mechanical ventilation demonstrated a reduction in ventilation time for epidurals when compared with controls (−0.32 h [95% CI −0.50 to −0.14], I 2 =82%, P=0.001) and is reported in Supplementary Fig. S6 .
Incidence of epidural haematoma
We identified 25 epidural haematomas in cardiac surgery (five from published reports, [12] [13] [14] [15] [16] four from grey literature 9 17 and further 16 from the anonymous web survey) from a total of 14 countries: Belgium (1), Brazil (1), France (1), Germany (2), India (2), Italy (1), Japan (2), Korea (1), Malaysia (1), Russia (3), Sweden (2), Turkey (1) United Kingdom (3), and United States (4). The source and location for the haematomas are shown in Table 2 . Two neurologic complications were excluded as they were not related to cardiac surgery (one patient with epidural use in refractory angina 18 and one patient with stroke, related to the management of the epidural catheter 19 Epidural in cardiac surgery | 27 
Discussion
Our study reports that the use of epidural in cardiac surgery reduces the risk of death, of mechanical ventilation and of myocardial infarction. The serious complication of epidural haematoma, and the number of epidurals performed in cardiac surgical procedures, is widely under-reported in the medical literature. However, the number of patients needed to treat to save a life is 70 and the number treated to harm (haematoma) is 1:3552, which confirms the relative safety of epidural use in cardiac surgery.
Even if the present study has several limitations (the metaanalysis included also case-matched non-randomized trials and the viral survey is not as precise as a mandatory register), it also gives important pieces of information to the physicians. Before this study, none of the randomized trials, cohort studies or meta-analyses had sufficient sample size to show a significant difference in mortality rate with epidurals, leading to a high risk of type II errors when concluding that a difference did not exist. Such trials have also been predominantly performed in lower-risk patients undergoing coronary artery surgery. This leads to a reduced event rate compared with all cardiac surgery and, therefore, requires an even larger sample size to show significance. The two most recent meta-analyses, 10 11 however showed similar direction and magnitude of mortality reduction to this study. The mechanism for a reduction in mortality with epidural is unknown. Use of high thoracic epidurals improves pain relief, 8 blunts the stress response to surgery, [20] [21] [22] produces coronary artery dilatation 23 and improves myocardial oxygen partial pressure, 24 may reduce stress-induced immunosuppression, 25 and allows a lower dose of general anaesthesia and systemic analgesia, 8 which in turn may lead to reduced myocardial injury, 10 26 shorter duration of mechanical ventilation, 8 27 improved physiotherapy co-operation, 20 less confusion development, 7 and reduced long term symptoms of depression 8 28 and post-traumatic stress disorder. 8 All of these are potential mechanism to improve healing and recovery, but we are unable to speculate from our data what the predominant mechanism is. We confirm, however, a reduction in myocardial infarction occurrence using epidural analgesia, which could contribute to reducing mortality in this surgical cohort. According to our data, and in agreement with previous investigations, ventilation time was also significantly reduced with epidurals, which could help patients' recovery by reducing the incidence of respiratory postoperative complications.
Epidural haematoma and consequent neurological damage including paraplegia is a potential risk for epidural use in all clinical situations including non-cardiac surgery, pain medicine and obstetrics. It is therefore an expected outcome that catheterrelated haematoma will occur with epidural usage in cardiac surgery. The controversy in cardiac surgery 9 29 relates to the question of whether the incidence of epidural haematoma will be increased compared with use in non-cardiac surgery, as a result of the full anticoagulation required for CPB. However, epidural haematoma patients were not reported until 2004, 12 and the only estimate before that was based on mathematical modelling of an event that had not yet occurred 5 and that led to very wide confidence intervals of risk, ranging from 1:1500 to 1:150 000 patients. 5 As the reporting of epidurals positioned in cardiac surgery increased over time, and with the publication of haematoma occurrence, the most recent risk assessment in 2007 was an estimated incidence of 1:12 000 patients (95% CI 1:2100-1:68 000), which was comparable with the risk assessment in non-cardiac surgery (1:10 000, 95% CI 1:6700-1:14 900). The largest case cohort study by Wijeysundera and colleagues reported an incidence of spinal laminectomy (which was presumed to be associated with epidural haematoma) of 1:4524 patients (95% CI 1:2695-1:9090), establishing a benchmark for risk in patients undergoing major non-cardiac surgery. 3 They also reported a risk of decompression laminectomy of 1:7246 (95% CI 1:5000-1:10 870) when epidurals were not used, reinforcing that not all epidural haematomas are caused by the insertion of an epidural catheter. We report a sample size nearly double of that by Wijeysundera and colleagues 3 and confirm that the risk of epidural haematoma, when using high thoracic epidural analgesia in cardiac surgery, is not increased compared with use in major non-cardiac surgery, where full anticoagulation is not required. It should be acknowledged that, even if the data we collected cannot confirm it (Table 2) , epidural hematoma might be triggered by repetitive punctures, bloody taps, impaired anticoagulation or excessive antiplatelet therapy, when the catheter is positioned or removed. Epidural usage has shown superior analgesia with reduction in ventilation time 8 27 and pulmonary complications. 11 30 It is also associated with a reduced incidence of supraventricular tachycardias 10 30 and less confusion. 30 Ultimately, it improves overall quality of recovery and promotes earlier hospital discharge. 27 Despite these potential advantages, however, in the setting of the risk of haematoma controversy, researchers have attempted to identify whether epidurals reduce mortality, in order to counterbalance the perceived risk of the technique. Overall, when investigating a new technique, it is often assumed by practitioners, that the novel approach is inherently more dangerous than the current established technique. The concept of risk-risk ratio, where the risk of the conventional approach is compared with the risk of the new technique, is difficult to perform in isolation, from the complexity of the surgical procedure Epidural in cardiac surgery | 29
and from all the factors involved in patients healing and recovery. Risk of mortality is a composite endpoint for all these factors. Our data show that the risk of death is less when using an epidural as part of the anaesthetic technique, and the risk:risk concept favours epidurals for cardiac surgery.
Finally, there are several limitations to our study. Firstly, our data on mortality and myocardial infarction are drawn from many small studies, none of which was adequately powered to measure mortality, and where mortality was measured at different time points. In addition, the RCTs were biased towards a coronary artery bypass population and lower risk cohorts than those represented in a typical cardiac surgery centre now. It is therefore possible that the effect size is larger than predicted by our analysis. Secondly, we incorporated case-matched studies, which include higher risk patients and on-pump cardiac surgery, other than isolated coronary artery bypass grafting. We assessed the quality of each study to reduce the risk of inclusion bias inherent in non-RCTs, and, when sensitivity analyses were performed, including only studies with low risk of bias and studies with low and intermediate risk of bias, no reduction in mortality was detected. We speculate that the reason is the significant reduction in sample size. Indeed, the most robust research method for both mortality and haematoma assessment would remain a very large scale RCT, but that is not practical and very unlikely to occur, and our study represents the best estimate of events available at the current time. Thirdly, when considering the risk of haematoma formation, it is possible that there are more unreported patients. However, this should also be balanced by more epidural insertions performed. In the absence of a larger prospective registry or very large scale RCT, we believe that our worldwide survey provides the best available approach to identifying the incidence of haematoma (numerator) and the associated number of epidurals performed (denominator). Prior risk estimates were skewed towards a lower risk estimate (if only RCT are included the incidence would be zero), or to a higher risk estimate if case reports were added as they presented the numerator without the associated denominator. Although our approach has limitations, we have captured an incidence of epidurals performed of more than five times the published literature, and likely to represent a substantial proportion of the worldwide experience using this technique. Fourthly, it could be argued that epidural has no importance in cardiac surgery because pain is not an issue in this setting. We therefore would like to underline that the findings of our manuscript support the hypothesis that epidural analgesia is beneficial on clinically relevant endpoints (e.g. mortality reduction) and that epidural in this setting is justified if performed to improve clinically relevant outcomes. Fifthly, the limitations of our survey also should be acknowledged: as it was a viral survey (with information spreading among colleagues) we did not have a 'response rate'; we asked the participants to estimate the numbers from their countries rather than to provide recorded data from their centres. Lastly, we only investigated haematoma as the serious complication, and not reports of epidural abscess, osteomyelitis, or direct neural lesions from needle trauma. However, there is no reason to think that peculiarities of cardiac surgery could influence the incidence of catheter-related adverse events other than haematoma in comparison with major non-cardiac interventions.
In conclusion, the use of epidural analgesia in cardiac surgery is associated with a reduction in mortality (NNT=70), against an estimated risk of epidural haematoma of 1:3552.
